BofA is spending big on GLP-1’s and AI invents a virus not found in nature for the first time
Summary
The episode explores the corporate debate over covering GLP-1 drugs, noting that while some employers see long-term health benefits, many are dropping coverage due to high costs and rising premiums. SpaceX’s stock rose despite a major share unlock, as investors absorbed the supply increase amid a unique phased release strategy. The hosts also highlight student-run real estate funds gaining traction, Stanford researchers using AI to design functional viruses for medical breakthroughs, and Meta facing a $567 million penalty for harming minors. Finally, they discuss Ford’s affordable electric …
Topics discussed
Intro, Vanguard ad, and show opening
BingeBuster website and physical media nostalgia
Bank of America's $250M GLP-1 drug bill
SpaceX stock unlock and share supply dynamics
Stock of the Week: Student-run real estate fund
Ads: Devil Wears Prada 2, Amazon, New York Life
Dog of the Week: AI-designed viruses
Meta fined $567M for teen safety violations
Ford Fathom: Affordable electric pickup truck
Florida steakhouse offers nude dining nights
Password game finale and credits
Listen ad-free on Castria